EP4076461
LÚMATEPERÓN TIL NOTKUNAR VIÐ MEÐFERÐ GEÐKLOFA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.12.2020EP published:
28.1.2026EP application number:
20900863.0
EP translation filed:
18.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
17.12.2040Expiry date:
17.12.2026
Title in English:
LUMATEPERONE FOR USE IN SCHIZOPHRENIA TREATMENTLanguage of the patent:
English
Timeline
Today
18.12.2020EP application
28.1.2026EP Publication
18.3.2026Translation submitted
8.4.2026Registration published
17.12.2026Expires
Owner
Name:
Intra-Cellular Therapies, Inc.Address:
135 Route 202/206, Suite 6, Bedminster, NJ 07921, US
Inventor
Name:
DAVIS, Robert E.Address:
New York, New York 10016, US
Name:
VANOVER, KimberlyAddress:
New York, New York 10016, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201962950828 PDate:
19.12.2019Country:
US
Classification
Categories:
A61K 31/4985, A61K 31/496, A61P 25/18, C07D 417/12, A61K 45/06